Vanguard Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $21.8M | Buy |
|
|||||
|
2019
Q4 | $29M | Buy |
|
|||||
|
2019
Q3 | $28.6M | Buy |
|
|||||
|
2019
Q2 | $33.7M | Buy |
|
|||||
|
2019
Q1 | $23.7M | Buy |
|
|||||
|
2018
Q4 | $14.9M | Sell |
|
|||||
|
2018
Q3 | $31.6M | Buy |
|
|||||
|
2018
Q2 | $34.7M | Buy |
|
|||||
|
2018
Q1 | $30.1M | Sell |
|
|||||
|
2017
Q4 | $24.2M | Sell |
|
|||||
|
2017
Q3 | $32.2M | Buy |
|
|||||
|
2017
Q2 | $29.2M | Buy |
|
|||||
|
2017
Q1 | $39M | Buy |
|
|||||
|
2016
Q4 | $24.4M | Buy |
|
|||||
|
2016
Q3 | $17.6M | Buy |
|
|||||
|
2016
Q2 | $11.6M | Buy |
|
|||||
|
2016
Q1 | $10.9M | Buy |
|
|||||
|
2015
Q4 | $14.6M | Buy |
|
|||||
|
2015
Q3 | $13.4M | Buy |
|
|||||
|
2015
Q2 | $16.9M | Buy |
|
|||||
|
2015
Q1 | $13.3M | Buy |
|
|||||
|
2014
Q4 | $15.8M | Buy |
|
|||||
|
2014
Q3 | $10.7M | Buy |
|
|||||
|
2014
Q2 | $8.28M | Buy |
|
|||||
|
2014
Q1 | $7.59M | Buy |
|
|||||
|
2013
Q4 | $7.82M | Sell |
|
|||||
|
2013
Q3 | $7.57M | Buy |
|
|||||
|
2013
Q2 | $5.61M | Buy |
|